首页|Amsterdam University Medical Center Reports Findings in Pancreatoduodenectomy (T ransatlantic differences in the use and outcome of minimally invasive pancreatod uodenectomy: an international multi-registry analysis)
Amsterdam University Medical Center Reports Findings in Pancreatoduodenectomy (T ransatlantic differences in the use and outcome of minimally invasive pancreatod uodenectomy: an international multi-registry analysis)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Surgery - Pancreatoduo denectomy is the subject of a report. According to news reporting originating fr om Amsterdam, Netherlands, by NewsRx correspondents, research stated, “Minimally invasive pancreatoduodenectomy (MIPD) has emerged as an alternative to open pan creatoduodenectomy (OPD). However, the extent of variation in the use and outcom es of MIPD in relation to OPD among countries is unclear as international studie s using registry data are lacking.” Our news editors obtained a quote from the research from Amsterdam University Me dical Center, “This study aimed to investigate the use, patient selection, and o utcomes of MIPD and OPD in four transatlantic audits for pancreatic surgery. A p ost hoc comparative analysis including consecutive patients after MIPD and OPD f rom four nationwide and multicenter pancreatic surgery audits from North America , Germany, the Netherlands, and Sweden (2014-2020). Patient factors related to M IPD were identified using multivariable logistic regression. Outcome analyses ex cluded the Swedish audit because <100 MIPD were performed during the studied period. Overall, 44,076 patients who underwent pancreatoduode nectomy were included (29,107 North America, 7586 Germany, 4970 the Netherlands, and 2413 Sweden), including 3328 MIPD procedures (8%). The use of MIPD varied widely among countries (absolute largest difference [ALD] 17%, p<0.001): 7% North America, 4% Germany, 17% the Netherlands, and 0.1% Sweden. Over time, the use of MIPD increased in North America and the Netherlands (p <0.001), mostly driven by robotic MIPD, but not in Germany (p = 0.297). Patient factors predicting the use of MIPD included country, later year of operation, better performance status, high POPF -risk score, no vascular resection, and nonmalignant indication. Conversion rat es were higher in laparoscopic MIPD (range 28-45%), compared to rob otic MIPD (range 9-37%). In-hospital/30-day mortality differed amon g North America, Germany, and the Netherlands; MIPD (2%, 7% , 4%; ALD 5%, p<0.001) and OPD ( 2%, 5%, 3%; ALD 3%, p<0.001), similar to major morbidity; MIPD (25%, 42%, 3 8%, ALD 17%, p<0.001) and OPD (2 5%, 31%, 30%, ALD 6%, p<0.001), respectively. Considerable differences were found in the use and outcom e, including conversion and mortality rates, of MIPD and OPD among four transatl antic audits for pancreatic surgery.”
AmsterdamNetherlandsEuropeEmerging TechnologiesGastroenterologyHealth and MedicineMachine LearningPancreasPancreatoduodenectomyRoboticsRobotsSurgery
NETL
NSTL
